Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 5/20 | 0.81 |
| ▸ | VDR | P11473 | 4/20 | 0.81 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.81 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.81 |
| ▸ | EPHA2 | P29317 | 4/20 | 0.76 |
| ▸ | CASP7 | P55210 | 3/20 | 0.76 |
| ▸ | TP53 | P04637 | 2/20 | 0.76 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.76 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.76 |
| ▸ | BLM | P54132 | 2/20 | 0.76 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.76 |
| ▸ | USP2 | O75604 | 2/20 | 0.76 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.76 |
| ▸ | MDM4 | O15151 | 1/20 | 0.76 |
| ▸ | MAPT | P10636 | 1/20 | 0.76 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.76 |
| ▸ | TSHR | P16473 | 1/20 | 0.76 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.76 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.76 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.76 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13648593 | 1.00 | GPBAR1 (0.81) | GPBAR1VDRHIF1ACYP2C9EPHA2 | |
| SCHEMBL19565489 | 1.00 | GPBAR1 (0.81) | GPBAR1VDRHIF1ACYP2C9EPHA2 | |
| SCHEMBL5442890 | 1.00 | GPBAR1 (0.81) | GPBAR1VDRHIF1ACYP2C9EPHA2 | |
| SCHEMBL5446368 | 0.96 | GPBAR1 (0.76) | GPBAR1VDRHIF1ACYP2C9EPHA2 | |
| SCHEMBL5446372 | 0.96 | GPBAR1 (0.76) | GPBAR1VDRHIF1ACYP2C9EPHA2 | |
| SCHEMBL5434273 | 0.92 | GPBAR1 (0.79) | GPBAR1VDRHIF1ACYP2C9EPHA2 | |
| SCHEMBL5434267 | 0.92 | GPBAR1 (0.79) | GPBAR1VDRHIF1ACYP2C9EPHA2 | |
| SCHEMBL139260 | 0.92 | GPBAR1 (0.75) | GPBAR1VDRHIF1ACYP2C9EPHA2 | |
| SCHEMBL139261 | 0.92 | GPBAR1 (0.75) | GPBAR1VDRHIF1ACYP2C9EPHA2 | |
| SCHEMBL5434017 | 0.91 | GPBAR1 (0.80) | GPBAR1VDRHIF1ACYP2C9EPHA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115819491-A | Synthesis method of 7-ketolithocholic acid and ursodeoxycholic acid | 江苏佳尔科药业集团股份有限公司 | 2023-03-21 | — | — | CN | disclosed |
| CN-102725633-B | The mensuration damaged for diagnosing cardiac muscle cell | ABBOTT LABORATORIES (US) | 2016-02-03 | — | — | CN | disclosed |
| CN-102725633-A | Assay for diagnosis of cardiac myocyte damage | ABBOTT LAB | 2012-10-10 | — | — | CN | disclosed |
| US-20070254247-A1 | Radiation-sensitive resin composition | YAMAMOTO MASAFUMI | 2007-11-01 | — | — | US | disclosed |
| US-20070179100-A1 | Protected monomers | ALNYLAM PHARMACEUTICALS, INC. | 2007-08-02 | — | — | US | disclosed |
| CN-1266192-C | Diamine compound, polyamic acid, imidized polymer, liquid crystal aligning agent and liquid crystal display element | JSR CO LTD (JP) | 2006-07-26 | — | — | CN | disclosed |
| US-7005230-B2 | Radiation-sensitive resin composition | JSR CORPORATION (JP) | 2006-02-28 | — | — | US | disclosed |
| EP-1625138-A2 | PROTECTED MONOMERS | Alnylam Pharmaceuticals Inc. (US) | 2006-02-15 | — | — | EP | disclosed |
| CN-1564840-A | Diamine compound, polyamic acid, imide polymer, liquid crystal alignment agent and liquid crystal display | JSR CO LTD (JP) | 2005-01-12 | — | — | CN | disclosed |
| WO-2004094345-A2 | PROTECTED MONOMERS | ALNYLAM PHARMACEUTICALS INC. (US) | 2004-11-04 | — | — | WO | disclosed |
| US-6800419-B2 | FOR USE AS CHEMICALLY-AMPLIFIED RESIST FOR MICROFABRICATION UTILIZING DEEP ULTRAVIOLET RAYS AND EXHIBITS EXCELLENT FILM THICKNESS UNIFORMITY AND STORAGE STABILITY | JSR CORPORATION (JP) | 2004-10-05 | — | — | US | disclosed |
| US-20040146802-A1 | Radiation-sensitive resin composition | JSR CORPORATION (JP) | 2004-07-29 | — | — | US | disclosed |
| US-20030203307-A1 | Radiation-sensitive resin composition | JSR CORPORATION (JP) | 2003-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070179100-A1 | Protected monomers | PCNA, POLN, PARP1 | GPBAR1 4124/4885VDR 4209/4885HIF1A 602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.